CS
RLYB icon

Credit Suisse’s Rallybio RLYB Stock Holding History

Credit Suisse’s Portfolio RLYB Stock Details RLYB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Hold
0
– -$7 – 3638
2022
Q4 		– Sell
-11
Closed -$649 – 3781
2022
Q3 		$1K Buy
11
+8
+267% +$713 ﹤0.01% 3914
2022
Q2 		$0 Buy
+3
New +$225 ﹤0.01% 4251

Other funds holding RLYB

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
CPX
Canaan Partners XI Menlo Park, California $76.1M AUM 638.59% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Credit Suisse's RLYB Position: Q1 2023 in Review

Credit Suisse held its Rallybio (RLYB) position steady in Q1 2023 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #3638.

Credit Suisse first reported a position in RLYB in Q2 2022 and has held it in 2 quarters since. The position peaked at $1K in Q3 2022. 53 funds tracked by Wall St. Rank hold RLYB as of Q1 2023.

  • Credit Suisse held 0 shares of Rallybio worth $0 as of Q1 2023.
  • Credit Suisse left its Rallybio share count unchanged in Q1 2023.
  • Rallybio made up ﹤0.01% of Credit Suisse's portfolio in Q1 2023, its #3638 holding.
  • Credit Suisse first reported a position in Rallybio in Q2 2022 and has held it in 2 quarters since.
  • Credit Suisse's Rallybio position peaked at $1K in Q3 2022.
  • 53 funds tracked by Wall St. Rank held Rallybio as of Q1 2023.

Based on Credit Suisse's 13F filing for Q1 2023, filed 10 May 2023.